← Open Payments lookup

LINDA HENTZ: Open Payments

NPI 1134632581 · LEXINGTON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,636 in 64 payments from 18 companies in 2025. Trend: 2023 $3,177 · 2024 $2,543 · 2025 $1,636

Food & beverage: $1,636
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.6$230
Teva Pharmaceuticals USA, Inc.10$216
Otsuka Pharmaceutical Development & Commercialization, Inc.2$173
Otsuka America Pharmaceutical, Inc.6$162
E.R. Squibb & Sons, L.L.C.5$116
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$97
Tris Pharma Inc5$95
Vanda Pharmaceuticals Inc.3$89
Corium, LLC5$87
Alkermes, Inc.4$84

Products named: INGREZZA, UZEDY, COBENFY, ABILIFY MAINTENA, CAPLYTA, Dyanavel XR, Azstarys, ARISTADA.

Industry payments across SC — which companies pay providers there.